Advertisement
Advertisement
BIOA
BioAge Labs, Inc. Common Stock
11.72
USDSponsored
+0.45
+3.99%
Aug 07, 15:59 UTC -4
Closed
After-Market
11.75
+0.03
+0.24%
BioAge Labs, Inc. Common Stock Profile
About
Info & Links
CEO
Kristen Fortney
Headquarters
Emeryville, CA 94608, UNITED STATES
Industry
Sector
Website
Auditor
KPMG LLP
Share holders
--
Employees
62
BioAge Labs, Inc. Common Stock Statistics
Valuation Measures
Market Capitalization2
539.20M
Enterprise Value
465.23M
Enterprise Value/EBITDA(ttm)
-4.39
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
51.95
Price to Book(mrq)
1.43
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
100.00%
Operating Margin(ttm)
-912.26%
Profit Margin(ttm)
-923.10%
Return on Equity(ttm)
-28.99%
Return on Invested Capital(ttm)
-29.64%
Return on Assets(ttm)
-27.09%
Income Statement
Revenue(ttm)
10.36M
Revenue Per Share(ttm)
0.23
Gross Profit(ttm)
10.36M
EBITDA(ttm)3
-106.02M
Net Income Available to Common(ttm)
-94.46M
Diluted EPS(ttm)
-2.38
Share Statistics
Beta (5Y Monthly)
0.93
52-Week Change
171.30%
S&P 500 52-Week Change
21.72%
S&P 500 Member
No
Stock Optionable
Yes
Total Shares Outstanding1
45.90M
Dividend Yield
0.00%
Float4
37.84M
% Held by Insiders
17.55%
% Held by Institutions
--
Balance Sheet
Total Cash(mrq)
318.75M
Total Cash Per Share(mrq)
6.94
Total Debt(mrq)
0.00
Total Debt/Equity(mrq)
0.00%
Current Ratio(mrq)
17.19%
Quick Ratio(mrq)
24.76%
Book Value Per Share(mrq)
8.19
Cash Flow
Operating Cash Flow Per Share(ytd)
-0.97
Free Cash Flow(ytd)
-43.66M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement